Flow Cytometry: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
Line 36: | Line 36: | ||
| | | | ||
'''[[MPO|<span style="color:maroon">'''MPO'''</span>]]''' | '''[[MPO|<span style="color:maroon">'''MPO'''</span>]]''' | ||
|} | |} | ||
Line 147: | Line 143: | ||
| | | | ||
'''[[HLA-DR|<span style="color:navy">'''HLA-DR'''</span>]]''' | '''[[HLA-DR|<span style="color:navy">'''HLA-DR'''</span>]]''' | ||
|} | |||
{|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 4px; margin: 5px" | |||
| | |||
'''[[IgM|<span style="color:maroon">'''IgM'''</span>]]''' | |||
|} | |} | ||
Revision as of 12:49, 1 June 2023
- Individual immunophenotypic markers used in diagnosis
- Reactivity patterns used to distinguish disorders (reactivity patterns)
- Immuonophenotype of specific conditions (disease specific patterns)
Markers used mainly for gating:
Non CD-classified markers
CD-classified markers frequently used in leukaemia diagnosis
Other markers helpful in diagnosis